risarestat has been researched along with Corneal Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosotani, H; Ohashi, Y; Tsubota, K; Yamada, M | 1 |
| Tsubota, K; Yamada, M | 1 |
| Fukuda, M; Matsuda, M; Ohashi, Y; Ohguro, N | 1 |
| Fukuda, M; Hosotani, H; Ishimoto, I; Manabe, R; Matsuda, M; Ohashi, Y; Tano, Y | 1 |
2 trial(s) available for risarestat and Corneal Diseases
| Article | Year |
|---|---|
Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112.
Topics: Aged; Aldehyde Reductase; Cornea; Corneal Diseases; Diabetes Complications; Diabetic Retinopathy; Epithelium; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Sensation; Thiazoles; Thiazolidinediones | 1995 |
Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients.
Topics: Administration, Topical; Aged; Aldehyde Reductase; Cell Size; Corneal Diseases; Diabetes Mellitus, Type 2; Endothelium, Corneal; Humans; Middle Aged; Thiazoles; Thiazolidinediones | 1995 |
2 other study(ies) available for risarestat and Corneal Diseases
| Article | Year |
|---|---|
The effect of aldose reductase inhibitor on the corneal epithelium.
Topics: Adult; Aldehyde Reductase; Cornea; Corneal Diseases; Epithelium; Female; Humans; Hypertrophy; Ophthalmic Solutions; Thiazoles; Thiazolidinediones | 1993 |
Aldose reductase inhibitor (CT-112) eyedrops for diabetic corneal epitheliopathy.
Topics: Aged; Aldehyde Reductase; Cornea; Corneal Diseases; Diabetes Complications; Epithelium; Humans; Male; Middle Aged; Ophthalmic Solutions; Recurrence; Sugar Alcohol Dehydrogenases; Thiazoles; Thiazolidinediones | 1988 |